Insider trade

Officer received an award of 13K ABT shares

Traded Mar 23, 2026 · Filed Mar 25, 2026

Abbott LaboratoriesABT

13K
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 23, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 25, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references tax withholding

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001263312-26-000004
Filed / recorded

Mar 25, 2026, 10:56 PM UTC

Added to OQRO

Oct 2, 2026, 12:26 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

ABBOTT LABORATORIES

Issuer CIK

1800

Ticker

ABT

Reporting person

Jacob A Orville

Relationship

Officer

Officer title

Senior Vice President

Security

Common shares without par value

Table

Non-derivative (Table I)

Transaction date

Mar 23, 2026

Transaction code

A

Shares / units

13,255

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

50,493

Ownership form

Direct

Amendment

No

Footnotes from the filing

These shares represent a restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 2-year term, with 1/2 of the award vesting in any one year, beginning on March 23, 2027. The award includes the right to have shares withheld for tax purposes.